Birch Hill's New Velan: A Deferral Quarter Disguised as a Fresh Start
Control has changed hands at the C$336M valve maker, but the operating story is the same one it has told for years — shipments pushed into 'future periods' while it bets the pivot on nuclear and defense.
VLN.TO · Earnings Call · 2026-07-10
A new chapter, a familiar book
After a long season of strategic limbo — a proposed sale to Flowserve that the French government killed in October 2023, an asbestos overhang, and a founding family that finally chose to cash out — Velan has a new owner. Birch Hill's acquisition of Velan Holdings' majority stake closed last month, and this Q1 2026 call was the first led by the new guard: Rishi Sharma as President and CEO, Imran Gibbons promoted to CFO, and Patrick Duncan (Birch Hill partner) installed as Chair. The framing was unambiguous:
With this transaction now completed, we are entering a new chapter in our history from a position of strength.
It is a tone that would have been hard to imagine three years ago, when the same management was in retreat after the failed deal. The Birch Hill era, in other words, opens exactly where the old one ended — with a promise to finally execute. On the prior January call, the outgoing CEO answered an analyst's question about whether he was staying with a placid “Yes, it's business as usual for us at Velan. Birch Hill has a long history of partnering and participating with management, and we don't see any change in that in the immediate future.” — James Mannebach, Chief Executive Officer · 2026-01-15 Three years earlier, the tone had been raw:
we are extremely disappointed by the outcome of the infinite transaction and exposure. And it's time for us now to revisit our corporate strategy to ensure that we can maximize the value creation for the shareholders.
The bookends frame the throughline of this company — a recurring deferral of its real story.
A deferral dressed as external noise
The quarter itself is weak, and the gap between the confident charter and the numbers is the first thing worth noting. Bookings fell to $48M from $78.2M a year ago, sales to $57.8M from $72.2M, adjusted EBITDA swung to a negative $2.1M from a positive $3.8M, and gross margin compressed from 28.6% to 19.6% (or roughly 22% excluding a $1.3M provision increase). Management's explanation landed early in the call:
“While results were below last year, it is important to note that most of the factors impacting our performance were external in nature, primarily relating to geopolitical and regional conflicts and its effect on our customer activity, order timing, and shipment schedules.” — Rishi Sharma · 2026-07-10
Shipments were deferred, with "the majority" expected to be recaptured by fiscal year end — a refrain this name knows intimately. Velan's own keyword history is essentially a palimpsest of push-out: Shipments was the single biggest momentum gainer on record back in 20233 (270), and future periods has been the company's top keyword for the latest reported quarter. The phrase does heavy lifting, parking revenue just out of sight.
The uncomfortable truth is that "external factors" have been the crutch before, each time with a different culprit — in 2023 it was the French government's veto of the Flowserve deal; now it is Middle East conflict and weak North American MRO activity. That distinction matters because MRO is short-cycle, same-quarter revenue; when it slips, the deferred dollars don't fully return with the long-duration nuclear contracts being booked in its place. The market's attention, meanwhile, is elsewhere entirely: the global curated keyword set for this quarter is dominated by tariff mechanics, IEEPA refund negotiations and trade-policy whipsaws — none of which appears in Velan's script. Velan's shock is political conflict, not tariff policy, a useful separation for anyone mapping this name onto the macro tape.
The quiet pivot underneath
Beneath the deferral narrative sits a genuine structural shift, and it is the most interesting content in the call. Backlog stood at $275M with about 70% deliverable in 12 months — down slightly — but management flagged that the mix is changing:
“our backlog is progressively evolving towards a structure that reflects a growing share of longer duration, large-scale contracts, particularly in the nuclear and defense sectors, which increases backlog visibility and extends delivery timelines.” — Rishi Sharma · 2026-07-10
Nuclear power remains the headline growth driver — CANDU refurbishments, the recently announced Nuclear Energy Strategy, and specifically the GEH SMR program, which management says is advancing through engineering and procurement, with conversion into bookings "in the near term" and revenue beginning within a 24-month execution window. It is a claim the company has telegraphed before — on the January call, the prior CEO said the GE Hitachi project "continues to progress very nicely" (a point we cited earlier in the thread) — but now there is a funded, committed partner pushing it forward.
More striking is the defense keyword, which spiked in momentum (179) last quarter and is essentially new to Velan's keyword lexicon: nuclear-propulsion valve applications for naval modernization. This is a company-unique theme, not sector boilerplate, and it hybrids with the nuclear franchise in a way few industrial valve makers can replicate — the same critical valves expertise sold into CANDU has a naval analogue that did not exist in the keyword record two years ago, when the top terms were asbestos provisions and administration costs.
Yet this is precisely the tension. The pivot toward long-duration nuclear and defense work is why near-term revenue keeps slipping into "future periods," and why absorption of fixed production overhead — a keyword that recurs in nearly every quarter — keeps dragging margins. The company has effectively chosen backlog quality over quarterly revenue, betting the equity story on the SMR cycle in Canada and the BWRX-300 program, while the Saudi joint venture targets Middle East infrastructure and refinery MRO. The result is a bifurcated book: short-cycle Gulf MRO, long-cycle North American nuclear and defense.
Balance sheet, and the wait
The financial position is the most credible part of the pitch. Cash of $34.6M at quarter end, and — the first real evidence of the PE owner's hand — a new five-year C$80M revolving credit facility signed after quarter end at a lower cost of capital, used to repay existing North American debt. The prior call was consumed by shareholder anger over a $13 buyout price versus a $17–18 market and over the company absorbing transaction costs; this quarter is the first where the new backer's capital is actually being deployed. The working-capital build — "securing material procurement ahead of executing long-term contracts," as the CFO put it — is the mechanism: cash consumed today to lock in execution on a backloaded, high-technology backlog.
It is, in the end, a wait-and-see quarter, and the wait is real. Tellingly, the call's Q&A was empty — the operator reported "There are no questions at this time." For a small-cap in the middle of a control transition with a headline growth narrative, investor silence reads as ambivalence. The "position of strength" framing is a promise, not yet a result. If the GEH SMR orders and defense-propulsion wins land as telegraphed, the recurring "future periods" keyword stops being an excuse and starts being an investment thesis. If they slip, Velan has simply replaced one deferred deal — the Flowserve sale — with another.